Evidence map›Paper›PMID 37998322›Full record

ArticleCells2023

Porcine UL-16 Binding Protein 1 Is Not a Functional Ligand for the Human Natural Killer Cell Activating Receptor NKG2D.

Kevin J Lopez, John Paul Spence, Wei Li, Wenjun Zhang, Barry Wei, Arthur A Cross-Najafi, James R Butler, David K C Cooper, Burcin Ekser, Ping Li

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. [Research and application progress for liver xenotransplantation].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Review
  3. Cytotoxic Responses Mediated by NK Cells and Cytotoxic T Lymphocytes in Xenotransplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kevin J LopezDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0002-5807-3136
John Paul SpenceDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Wei LiDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Wenjun ZhangDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0001-9801-0634
Barry WeiDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Arthur A Cross-NajafiDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
James R ButlerDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
David K C CooperCenter for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
Burcin EkserDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0003-0741-8007
Ping LiDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Indiana University School of MedicineHarvard University · US

Funding

Tumor Microenvironment and Metastasis ProgramP30CA082709 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI David W Clapp · 1999 to 2026
$59.3M
Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammationU19AI090959 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COOPER, DAVID KC · 2010 to 2024
$26.3M
Project-005U54DK106846 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Reuben Kapur, Karen Elizabeth Pollok · 2015 to 2026
$9.7M
Short-Term Training Program In Biomedical SciencesT35HL110854 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI Brittney-Shea Herbert, Catherine Rufatto Sears · 2012 to 2026
$3.4M
BD FACSAria SystemS10OD012270 · OD · INDIANA UNIVERSITY INDIANAPOLIS · PI SROUR, EDWARD F · 2013 to 2013
$516k
Development of novel strategies to modulate human NK cell response in xenotransplantationR21AI164002 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI LI, PING · 2021 to 2022
$436k
NCI NIH HHS P30 CA082709NHLBI NIH HHS T35 HL110854NIAID NIH HHS R21 AI164002NIAID NIH HHS U19 AI090959NIDDK NIH HHS U54 DK106846NIH HHS S10 OD012270
6 · The paper itself

Abstract

Natural killer (NK) cells play a vital role in xenotransplantation rejection. One approach to induce NK cell immune tolerance is to prevent the NK cell-mediated direct killing of porcine cells by targeting the interaction of the activating receptor NKG2D and its ligands. However, the identity of porcine ligands for the human NKG2D receptor has remained elusive. Previous studies on porcine UL-16 binding protein 1 (pULBP-1) as a ligand for human NKG2D have yielded contradictory results. The goal of the present study was to clarify the role of pULBP-1 in the immune response and its interaction with human NKG2D receptor. To accomplish this, the CRISPR/Cas9 gene editing tool was employed to disrupt the porcine

Indexed as

Endothelial CellsNK Cell Lectin-Like Receptor Subfamily KAnimalsHumansKiller Cells, NaturalLigandsReceptors, Natural Killer CellSwineLigandsNK Cell Lectin-Like Receptor Subfamily KReceptors, Natural Killer Cellgene editingimmune rejectionnatural killer (NK) cellNKG2DULBP-1xenotransplantation

Identifiers

PMID37998322
PMCPMC10670462
OpenAlexW4388464960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.